Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Maia Biotechnology Inc (MAIA)

Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Maia Biotechnology Inc 444 WEST LAKE STREET SUITE 1700 CHICAGO IL 60606 USA

www.maiabiotech.com Employees: 13 P: 312-416-8592

Sector:

Medical

Description:

MAIA Biotechnology Inc. is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. The Company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of patients with telomerase-positive cancers. MAIA Biotechnology Inc. is based in CHICAGO.

Key Statistics

Overview:

Market Capitalization, $K 86,655
Enterprise Value, $K 77,055
Shares Outstanding, K 37,032
Float, K 25,063
% Float 67.68%
Short Interest, K 1,654
Short Float 4.47%
Days to Cover 2.73
Short Volume Ratio 0.33
% of Insider Shareholders 32.32%
% of Institutional Shareholders 5.65%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -23,250 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,900 K
EBIT, $ -24,960 K
EBITDA, $ -24,960 K

Growth:

1-Year Return 25.00%
3-Year Return -47.83%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/07/25
Next Earnings Date 03/20/26
Earnings Per Share ttm -0.78
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year -145.45%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MAIA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -757.45%
Return-on-Assets % -211.06%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -2.35
60-Month Beta -0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar